Search Results 1851-1860 of 17030 for pharmacogenetics
This episode of "Tomorrow's Cure" explores how a type of blood cancer, chronic lymphocytic leukemia (CLL), is hard to detect early in its development and ...
At Mayo Clinic, biomedical engineer Benjamin Brinkmann, Ph.D., is developing tools and technologies that help reveal brain patterns — making epileptic seizures ...
According to U.S. health officials, the number of acute respiratory illnesses causing people to seek medical care remains at a high level. Seasonal influenza ...
Learn about the expertise and services, including travel medicine, offered at Mayo Clinic to people with concerns about infectious diseases.
This randomized phase III trial compares memantine hydrochloride and whole-brain radiotherapy with or without hippocampal avoidance in reducing neurocognitive ...
Mayo Clinic researchers and collaborators zeroed in on the mechanism by which different forms of a protein associated with frontotemporal dementia could affect ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic researchers are using technology to produce tissue models of different body parts to study damaged or diseased tissues and organs. They envision a[.
Imagine knowing your risk for disease long before symptoms appear. With early detection and targeted interventions, this knowledge could transform how complex ...
Monoclonal antibodies, such as ipilimumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.